Article
Clinical and molecular characterization of the potential CF disease modifier syntaxin 1A.
European journal of human genetics : EJHG - 1 Dec 2013
von Kanel Thomas, Stanke Frauke, Weber Melanie, Schaller Andre, Racine Julien, Kraemer Richard, Chanson Marc, Tümmler Burkhard, Gallati Sabina
Abstract excerpt
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator gene (CFTR). Disease severity in CF varies greatly, and sibling studies strongly indicate that genes other than CFTR modify disease outcome. Syntaxin 1A (STX1A) has been reported as a negative regulator of CFTR and other ion channels. We hypothesized that STX1A variants act as a CF modifier by influencing the remaining...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
